Primary cell experiments with TG101348, a JAK2-selective inhibitor, in the presence of myeloproliferative disorder-associated JAK2V617F, MPLW515L/K, and JAK2 exon 12 mutations Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Lasho, Terra L
  • Finke, Christy
  • Hood, John D
  • Soll, Roger
  • Noronha, Glenn
  • Mesa, Ruben A
  • Jamieson, Catriona
  • Verstovsek, Srdan
  • Cortes, Jorge
  • Kantarjian, Hagop
  • Gilliland, D Gary
  • Tefferi, Ayalew
  • Pardanani, Animesh

publication date

  • November 16, 2007

published in